Dibasic Potassium Phosphate 236 + Monobasic Potassium Phosphate is a prescription medicine used in hospitals to treat severe low potassium and phosphorus levels in the body. It contains a combination of Dibasic Potassium Phosphate and Monobasic Potassium Phosphate, which help restore important electrolytes needed for normal muscle, nerve, and metabolic functions. This injection is usually given to critically ill patients or those who cannot take supplements by mouth. Because it is highly concentrated, it must be diluted before administration under medical supervision.
Dibasic Potassium Phosphate 236 + Monobasic Potassium Phosphate is an intravenous phosphate replacement medicine used in hospitals to treat low phosphate levels in the blood. It contains Dibasic Potassium Phosphate and Monobasic Potassium Phosphate, which supply phosphorus along with potassium. The injection is generally given when oral phosphate supplements cannot be used or when phosphate levels need to be corrected more quickly.
Phosphate is important for many body functions, including energy production, muscle movement, nerve signalling, and bone health. Low phosphate levels can develop in patients with severe illness, poor nutrition, chronic alcohol use, diabetic ketoacidosis, or in those receiving long-term intravenous nutrition.
Dibasic Potassium Phosphate 236 + Monobasic Potassium Phosphate is administered as a slow intravenous infusion after dilution and should only be given under medical supervision. Because the medicine also contains potassium, doctors may monitor electrolyte levels and kidney function during treatment to reduce the risk of complications such as high potassium or low calcium levels.
Dibasic Potassium Phosphate 236 + Monobasic Potassium Phosphate may be indicated by your doctor for:
A critical drop in blood phosphorus levels that can lead to muscle weakness, confusion, or acute respiratory failure.
Critically low levels of potassium in the blood, which can trigger severe heart rhythm abnormalities or severe muscle paralysis.
Providing essential minerals to critically ill, intensive care, or post-surgical patients who are receiving all their nutritional requirements through an intravenous fluid bag.
Dibasic Potassium Phosphate 236 + Monobasic Potassium Phosphate may provide benefits such as:
Doctors usually monitor phosphate, potassium, calcium, and kidney function during treatment to reduce the risk of complications.
Dibasic Potassium Phosphate 236 + Monobasic Potassium Phosphate is used to replace phosphate in people with low blood phosphate levels (hypophosphatemia). Phosphate is an important mineral involved in energy production, muscle and nerve function, bone health, and many cellular processes in the body.
Dibasic potassium phosphate and monobasic potassium phosphate provide phosphate ions that are absorbed into the bloodstream and used by cells throughout the body. Phosphate is required for the formation of ATP (adenosine triphosphate), which stores and transfers energy inside cells.
These salts also provide potassium, an electrolyte that helps maintain normal muscle contraction, nerve signaling, and heart function. Restoring phosphate levels helps support normal cellular metabolism and organ function when phosphate deficiency is present.
Together, the ingredients in Dibasic Potassium Phosphate 236 + Monobasic Potassium Phosphate help correct phosphate depletion and support normal electrolyte and metabolic balance.
Dibasic Potassium Phosphate 236 + Monobasic Potassium Phosphate should be avoided in patients with known allergy to phosphate salts or any ingredient in the injection. Seek medical attention if a rash, swelling, or difficulty breathing occurs after administration.
Limited information is available regarding the use of Dibasic Potassium Phosphate 236 + Monobasic Potassium Phosphate during breastfeeding. It should be used only if clearly needed and under medical supervision.
Dibasic Potassium Phosphate 236 + Monobasic Potassium Phosphate should be used during pregnancy only if prescribed by a doctor. Careful monitoring of electrolyte levels may be required during treatment.
Dibasic Potassium Phosphate 236 + Monobasic Potassium Phosphate is not generally expected to affect alertness or the ability to drive or operate machinery.
Excessive alcohol intake may contribute to electrolyte imbalance and dehydration, which can affect treatment response during phosphate replacement therapy.
Patients with severe liver disease may require careful monitoring of electrolyte balance during treatment with Dibasic Potassium Phosphate 236 + Monobasic Potassium Phosphate.
Dibasic Potassium Phosphate 236 + Monobasic Potassium Phosphate should be used with extreme caution in patients with severe kidney disease, as phosphate and potassium accumulation may increase the risk of serious complications such as hyperkalemia or hyperphosphatemia.
Since this medication is prepared and administered directly by hospital staff during acute or nutritional care, a missed dose is highly unlikely.
Checkout Editorial Policy